Obesity: Epidemiology, Pathophysiology, and PreventionDebasis Bagchi, Harry G. Preuss CRC Press, 7. mar. 2007 - 592 strani The obesity epidemic has spawned an unlimited array of quick-fix, rapid weight loss plans and unproven pharmaceuticals. Dangerous side effects and rebound weight gain has made the cure seem worse than the syndrome itself and left people uncertain where to turn. The only way to safely deal with the global obesity problem is to develop strategic ther |
Vsebina
Chapter 1 Epidemiology of Obesity | 3 |
A Global Burden for the New Millennium | 21 |
Pathophysiology of Obesity | 31 |
Chapter 3 Environmental Estrogens Endocrine Disruption and Obesity | 33 |
Chapter 4 Cigarette Smoking Inflammation and Obesity | 43 |
Chapter 5 Disordered Eating as a Correlate in the Development of Obesity | 63 |
Chapter 6 Role of Neurotransmitters in Obesity Regulation | 71 |
Chapter 7 Neurobiology of Obesity | 81 |
A Review of the Literature | 279 |
Chapter 23 Vegetarian Diets in the Prevention and Treatment of Obesity | 299 |
Chapter 24 The Atkins Paradigm | 315 |
Chapter 25 Polyphenols from Fruits and Vegetables in Weight Management and Obesity Control | 321 |
Chapter 26 Chromium III in Promoting Weight Loss and Lean Body Mass | 339 |
Chapter 27 An Overview on Hydroxycitric Acid in Obesity Regulation | 349 |
Chapter 28 A Review of the Safety and Efficacy of Citrus aurantium in Weight Management | 371 |
From the Biomedical Immune Viewpoint | 383 |
Link Between Metabolism and Vasculature | 93 |
Chapter 9 Overview of Ghrelin Appetite and Energy Balance | 105 |
Role of DNA Methylation | 115 |
Obesity and Degenerative Disease | 121 |
Chapter 11 Oxidative Stress Status in Humans with Metabolic Syndrome | 123 |
Chapter 12 Obesity and Type 2 Diabetes | 139 |
Chapter 13 AngiogenesisTargeted RedoxBased Therapeutics | 155 |
Chapter 14 Obesity as an Occult Risk Factor for Drug and Chemical Toxicities | 165 |
Novel Concept in Obesity Drug Development | 175 |
Chapter 15 Adipose Drug Targets for Obesity Treatment | 177 |
Safety of Obesity Drugs | 197 |
Chapter 16 Safety of Obesity Drugs | 199 |
Natural Nutritional and Physical Approaches to Weight Management | 217 |
Chapter 17 The Fundamental Role of Physical Activity and Exercise in Weight Management | 219 |
An Overview | 233 |
Chapter 19 Gender Differences in Body Fat Utilization During Weight Gain Loss or Maintenance | 239 |
Chapter 20 Appetite Body Weight Health Implications of a LowGlycemicLoad Diet | 245 |
The AntiAging Effects of Caloric Restriction | 265 |
Chapter 30 The Role of Tea in Weight Management | 401 |
Chapter 31 Laboratory and Clinical Studies of Chitosan | 413 |
Chapter 32 Phaseolus vulgaris and Amylase Inhibition | 423 |
A Review of the Evidence | 433 |
Chapter 34 Role of Caralluma fimbriata in Weight Management | 443 |
Chapter 35 Role of MediumChain Triglycerides in Weight Management | 451 |
Chapter 36 AntiObesity by Marine Lipids | 463 |
Chapter 37 Dairy Foods Calcium and Weight Management | 477 |
Chapter 38 Lessons from the Use of Ephedra Products as Dietary Supplements | 495 |
A Dietitians Perspective | 507 |
Child Obesity and Prevention | 513 |
Chapter 40 Treatment and Prevention of Childhood Obesity and Associated Metabolic Diseases | 515 |
Bariatric Surgery in Weight Management | 529 |
Chapter 41 Bariatric Surgery in Obesity and Reversal of Metabolic Disorders | 531 |
| 545 | |
Back cover | 571 |
Druge izdaje - Prikaži vse
Obesity: Epidemiology, Pathophysiology, and Prevention Debasis Bagchi,Harry G. Preuss Predogled ni na voljo - 2007 |
Pogosti izrazi in povedi
action activity addition adipocytes adipose tissue adults animals associated blood body fat body weight calcium calories carbohydrate cardiovascular cause cells changes Citrus aurantium Clin clinical compared consumed containing decreased demonstrated diet dietary disease disorders dose drugs eating effects energy et al evidence exercise expression extract factors fatty acids food intake function gene ghrelin glucose Health heart hormone human hydroxycitric acid important improve increased individuals induced inhibition inhibitor insulin resistance involved leptin levels lipid lower mass meal mean mechanisms Metab metabolic mice Nutr Nutrition Obes obesity observed overweight oxidation patients physical placebo plasma potential prevention protein rats receptor reduced regulation reported response risk role showed shown signaling significant significantly subjects suggest supplements syndrome treatment trial type 2 diabetes vegetarian weeks weight loss women